Intubation Scope Intended to provide optical visualization of, therapeutic access to, and use to facilitate routine or difficult tracheal intubations of the Upper Airway. This anatomy includes, but is not restricted to, the organs, tissues and subsystems: Larynx and Trachea. The instrument is introduced via the mouth or the nose, as decided by the physician, when indications consistent with the need for procedure are observed in adult and pediatric patient populations.
Publicado el 6 de julio de 2016 · Inicio del retiro: 6 de abril de 2016
Resumen
FDA registra el retiro Z-2072-2016 de dispositivos médicos de Clase II, publicado el 6 de julio de 2016 e iniciado el 6 de abril de 2016. Empresa responsable: Pentax Medical Company; Estado: Finalizado; Cantidad reportada: 1,220 units; Lote: Model #'s FI-10BS, FI-10P2, FI-10RBS, FI-13BS, FI-13P, FI-13RBS, FI-16BS, FI-16RBS, FI-9BS and FI-9RBS. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Pentax Medical Company
- Distribuidor
- Worldwide Distribution - US (Nation Wide) including Puerto Rico and Internationally to Denmark, Guam
- Lote
- Model #'s FI-10BS, FI-10P2, FI-10RBS, FI-13BS, FI-13P, FI-13RBS, FI-16BS, FI-16RBS, FI-9BS and FI-9RBS
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDASignmoidoscope Product Usage: Intended to provide optical visualization of, therapeutic access to the Lower3 de agosto de 2016
- FDABronchoscope Intended to provide optical visualization of and therapeutic access to the Airway and Bronchial6 de julio de 2016
- FDAColonoscope Intended to provide optical visualization of and therapeutic access to the Lower Gastrointestinal6 de julio de 2016
- FDALaryngo Stroboscope Product Usage Intended to provide optical visualization of, therapeutic access to, the6 de julio de 2016
- FDASaw Sagittal Catalog Number: ES 300; Saw Sagittal Refurbished Catalog Number: ES300-R; Saw Saggital, Finger6 de julio de 2016
- FDAAlaris System PC Unit Model 8015 with software versions 9.17 and 9.19; Central programming, monitoring and6 de julio de 2016
Preguntas sobre este retiro
¿Intubation Scope Intended to provide optical visualization of, therapeutic access to, and use to facilitate routine or difficult tracheal intubations of the Upper Airway. This anatomy includes, but is not restricted to, the organs, tissues and subsystems: Larynx and Trachea. The instrument is introduced via the mouth or the nose, as decided by the physician, when indications consistent with the need for procedure are observed in adult and pediatric patient populations. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2072-2016 el 6 de julio de 2016. Peligro reportado: Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter